Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Siemens Healthineers, Beckman Coulter, Becton Dickinson, Others Receive FDA Clearances in March

Siemens Healthineers, Beckman Coulter, Becton Dickinson, Others Receive FDA Clearances in March

Apr 05, 2019
|
staff reporter

NEW YORK (360Dx) – During March, the US Food and Drug Administration cleared in vitro diagnostic tests from Siemens Healthineers, Beckman Coulter, Becton Dickinson, Abbott, and others, according to the agency's website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Regulatory News & FDA Approvals

  1. DiaSorin Receives CE Mark to Use Saliva Samples With COVID-19 Test

  2. Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

  3. FDA Proposes Reclassification of Cytomegalovirus Quantitative Tests

  4. Cytek Biosciences Gets CE Mark for Flow Cytometer

  5. Eurobio Gets CE Mark for Multiplexed SARS-CoV-2, Influenza A/B, RSV Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.